Dr. Nicholas Lauterbach explains the impact of PRRSV and why it remains one of the costliest diseases for pork producers. The discussion focuses on the efficacy of a modified live immunization strategy during a PRRSV challenge, using a study designed to reflect real-world production conditions.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.